Clinical Trial: Nemolizumab for LS

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704775) titled 'Nemolizumab for LS' on June 09.

Brief Summary: Patients >= 18 years of age with Lichen sclerosis (LS)

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Lichen Sclerosus of Vulva

Intervention: BIOLOGICAL: Nemolizumab 30 mg

Participants will be treated with subcutaneous (SC) nemolizumab injections at doses determined by patient weight.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: University of Texas Southwestern Medical Center

Information provided by (Responsible Party): Melissa Mauskar, University of Texas Southwestern Medical Center

Disclaimer: Curated by HT Syndication....